Skip to main content

Advertisement

Table 3 Quality of life scores in patients randomised to fluticasone or placebo.

From: Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial

  Fluticasone Placebo   
  Mean difference at 12 months Mean difference at 12 months Effect size % partial eta2 Significance between groups
SGRQ total score -0.98 -1.43 < 0.1% P = 0.83
EQ5D total score -0.03 0.03 0.2% P = 0.66
EQ5D VAS -2.16 -0.29 < 0.1% P = 0.97
  1. (a) SGRQ = St George's respiratory questionnaire.
  2. (b) EQ5D = EuroQol 5D generic questionnaire.
  3. (c) Significance between groups was assessed using analysis of co-variance.